Show simple item record

dc.contributor.authorO'Toole, EA
dc.contributor.authorKelsell, DP
dc.contributor.authorCaterina, MJ
dc.contributor.authorde Brito, M
dc.contributor.authorHansen, D
dc.contributor.authorHickerson, RP
dc.contributor.authorHovnanian, A
dc.contributor.authorKaspar, R
dc.contributor.authorLane, EB
dc.contributor.authorPaller, AS
dc.contributor.authorSchwartz, J
dc.contributor.authorShroot, B
dc.contributor.authorTeng, J
dc.contributor.authorTiteux, M
dc.contributor.authorCoulombe, PA
dc.contributor.authorSprecher, E
dc.date.accessioned2024-01-09T09:28:34Z
dc.date.available2023-10-23
dc.date.available2024-01-09T09:28:34Z
dc.date.issued2023-12-14
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/93620
dc.description.abstractPachyonychia congenita (PC) is a dominantly inherited genetic disorder of cornification. PC stands out among other genodermatoses because despite its rarity, it has been the focus of a very large number of pioneering translational research efforts over the past 2 decades, mostly driven by a patient support organization, the Pachyonychia Congenita Project. These efforts have laid the ground for innovative strategies that may broadly impact approaches to the management of other inherited cutaneous and noncutaneous diseases. This article outlines current avenues of research in PC, expected outcomes, and potential hurdles.en_US
dc.languageeng
dc.relation.ispartofJ Invest Dermatol
dc.subjectDrug repurposingen_US
dc.subjectGenodermatosisen_US
dc.subjectKeratodermaen_US
dc.subjectNailsen_US
dc.subjectPachyonychia congenitaen_US
dc.titlePachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches.en_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.jid.2023.10.030
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38099888en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
dcterms.dateAccepted2023-10-23


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record